Nuclear medicine in hematology: Bridging diagnostics and therapy.

The investigation and therapeutic trials of hematological and hemato-oncological diseases using nuclear medicine methods dates back to the 1930s. At that time, 32P was used as the isotope for various experimental procedures. Over the years, a wide va…

Preview only. Read the full abstract at the source